Stevens Capital Management’s Avanos Medical AVNS Stock Holding History

Stevens Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-10,358	Closed	-$452K	–	555
2019 Q2	$452K	Buy	+10,358	New	+$443K	0.02%	473
2018 Q3	–	Sell	-19,457	Closed	-$1.11M	–	723
2018 Q2	$1.11M	Buy	+19,457	New	+$1.03M	0.04%	417
2017 Q2	–	Sell	-30,723	Closed	-$1.17M	–	853
2017 Q1	$1.17M	Buy	+30,723	New	+$1.2M	0.04%	386
2016 Q4	–	Sell	-10,645	Closed	-$369K	–	866
2016 Q3	$369K	Buy	+10,645	New	+$373K	0.02%	641
2015 Q4	–	Sell	-9,307	Closed	-$265K	–	921
2015 Q3	$265K	Sell	9,307 -1,249	-12%	-$43.6K	0.01%	740
2015 Q2	$428K	Buy	+10,556	New	+$474K	0.02%	654
2015 Q1	–	Sell	-10,085	Closed	-$459K	–	977
2014 Q4	$459K	Buy	+10,085	New	+$396K	0.02%	606

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Stevens Capital Management's AVNS Position: Q3 2019 in Review

Stevens Capital Management sold out of Avanos Medical (AVNS) in Q3 2019, closing a stake of 10,358 shares — an estimated $452K sold.

Stevens Capital Management first reported a position in AVNS in Q4 2014 and held it in 7 quarters. The position peaked at $1.17M in Q1 2017. 290 funds tracked by Wall St. Rank hold AVNS as of Q3 2019.

Stevens Capital Management reported no remaining Avanos Medical position as of Q3 2019 after selling out during the quarter.
Stevens Capital Management sold 10,358 Avanos Medical shares in Q3 2019, an estimated $452K.
Stevens Capital Management first reported a position in Avanos Medical in Q4 2014 and held it in 7 quarters.
Stevens Capital Management's Avanos Medical position peaked at $1.17M in Q1 2017.
290 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2019.

Based on Stevens Capital Management's 13F filing for Q3 2019, filed 8 Nov 2019.